Yervoy® (Ipilimumab)

Yervoy® (Ipilimumab) Ipilimumab 50 mg/10 mL (5 mg/mL) injection for intravenous infusion by Bristol-Myers Squibb. Genuine stock supplied in bulk/wholesale quantities to hospitals and pharmacies across India by A.K. Pharma, a licensed pharmaceutical distributor in Delhi.

Additional information

Composition

Ipilimumab 50 mg/10 mL (5 mg/mL)

Manufacturer

Bristol-Myers Squibb

Country

USA

Pack size

Ipilimumab 50 mg/10 mL (5 mg/mL): 1 vial / carton

Storage

As per carton and leaflet; original pack

Prescription medicine

Supplied only against a valid prescription from a registered medical practitioner.

100% genuine

Sourced from authorised channels

Cold-chain delivery

Temperature-controlled packing

Pan-India delivery

Hospitals, clinics, pharmacies

Licensed distributor

Delhi drug licence holder

Product information

Yervoy® (Ipilimumab) Ipilimumab 50 mg/10 mL (5 mg/mL) Injection for Intravenous Infusion — CTLA-4 Blocking Antibody: A Sourcing Guide for Hospitals and Oncology Pharmacies

Yervoy® is a brand of ipilimumab, a cytotoxic T-lymphocyte antigen 4 (CTLA-4) blocking monoclonal antibody, marketed by Bristol-Myers Squibb. According to the current US prescribing information, Yervoy is indicated as a single agent or in combination with nivolumab for melanoma, and in combination with nivolumab for renal cell carcinoma, MSI-H/dMMR colorectal cancer, hepatocellular carcinoma and non-small cell lung cancer, in the settings described in the label. Indications for Yervoy in India are defined by its approved pack insert and the Indian regulator. The decision to prescribe ipilimumab, including patient selection, dose and monitoring, rests entirely with the treating physician. This page provides sourcing and procurement information for hospitals and pharmacies, not clinical or treatment guidance.

As both a trusted medicine distributor in Delhi and a licensed pharmaceutical distributor in Delhi, A.K. Pharma supplies genuine Yervoy® (ipilimumab) Ipilimumab 50 mg/10 mL (5 mg/mL) injection for intravenous infusion to hospitals, oncology centres and pharmacies across India. Buyers comparing pharmaceutical distribution companies and wholesale pharmaceutical distributors can also browse our full product range and the cancer medicines category. Supply is in bulk/wholesale quantities only.


What is Yervoy (Ipilimumab)?

Yervoy contains ipilimumab, a human monoclonal antibody supplied as a single-dose vial for intravenous infusion. The Yervoy pack shown on this page states 50 mg/10 mL (5 mg/mL).

How it works, according to the label: The reference label describes ipilimumab as a CTLA-4 blocking antibody. The label warns that it can cause severe and fatal immune-mediated adverse reactions in any organ system.


Indications as Listed in the Reference Label

The current US prescribing information for YERVOY® (ipilimumab) injection (DailyMed) lists the following. Indications in India may differ and are defined by the Indian regulator and the Yervoy pack insert.

  • Unresectable or metastatic melanoma in adults and pediatric patients 12 years and older, as a single agent or with nivolumab
  • Adjuvant treatment of cutaneous melanoma with pathologic involvement of regional lymph nodes after complete resection
  • Intermediate or poor-risk advanced renal cell carcinoma, first-line in combination with nivolumab
  • MSI-H or mismatch repair deficient colorectal cancer, and hepatocellular carcinoma, in combination with nivolumab as specified in the label
  • Metastatic non-small cell lung cancer expressing PD-L1 (1% or more) without EGFR or ALK aberrations, first-line in combination with nivolumab, as specified in the label
  • The label lists no contraindications

Clinical Studies and Evidence

The Yervoy label summarises its Clinical Studies by indication. In previously treated metastatic melanoma, the MDX010-20 trial compared ipilimumab with or without a gp100 peptide vaccine against the vaccine alone; it was published by Hodi et al. in the New England Journal of Medicine in 2010. Full results are in the DailyMed prescribing information. Evidence is cited for information only and is not a recommendation for any patient; the approved prescribing information governs.


Available Presentation

Strength Dosage form Pack size (as shown on the carton)
Ipilimumab 50 mg/10 mL (5 mg/mL) Injection for intravenous infusion (single-dose vial) 1 vial / carton

Please confirm the current pack and batch with us before ordering. Dose and regimen must be determined and followed exactly as directed by the treating physician and the approved prescribing information.


Key Benefits for Procurement

  • Genuine, sealed original-pack stock sourced through authorised channels
  • Original manufacturer packaging with batch and expiry details
  • Batch and expiry details provided on request
  • Careful handling and storage of stock before dispatch
  • Documentation support for hospital purchase departments

Who Is This Page For?

This page is written for hospital pharmacists, oncology department buyers and pharmacies that source biologic oncology products. Ipilimumab is prescribed and supervised by a physician, as described in the prescribing information.


Possible Side Effects Reported in the Label

The Yervoy label lists, as most common adverse reactions (20% or more) as a single agent, fatigue, diarrhea, pruritus, rash, nausea and headache, with a longer list in combination with nivolumab. Its warnings cover severe and fatal immune-mediated adverse reactions, including colitis, hepatitis, dermatologic reactions, endocrinopathies, pneumonitis and nephritis, as well as infusion-related reactions and embryo-fetal toxicity. This list is not complete; the full prescribing information governs.


Precautions

  • The label lists no contraindications.
  • The label warns of severe and fatal immune-mediated adverse reactions that may require corticosteroids and withholding or discontinuing therapy, as determined by the treating physician.
  • The label describes monitoring for immune-mediated reactions and infusion-related reactions during treatment.
  • The label describes embryo-fetal toxicity and advises effective contraception, as determined by the treating physician.
  • All use should follow the approved prescribing information and the instructions of the treating physician.

All use should follow the approved prescribing information and the instructions of the treating physician.


Storage and Handling

Please follow the storage instructions printed on the Yervoy carton and leaflet. For reference, the US label describes refrigeration at 2°C to 8°C in the original carton, protected from light, and states not to freeze or shake. Keep out of reach of children.


Manufacturer Information

Yervoy is marketed by Bristol-Myers Squibb. A.K. Pharma is a licensed distributor and does not manufacture the product. As one of the pharmaceutical distributors serving Indian hospitals, we source Yervoy through authorised channels and supply it with pack and batch details. Buyers comparing a pharmaceutical wholesale distributors list or a pharma distribution company can verify our credentials on the About Us page.


Related Medicines


Frequently Asked Questions

Is Yervoy available in India?
A.K. Pharma supplies Yervoy (ipilimumab) Ipilimumab 50 mg/10 mL (5 mg/mL) injection for intravenous infusion to hospitals and pharmacies in India. Contact us for current availability.

What does Yervoy contain?
Ipilimumab, a CTLA-4 blocking monoclonal antibody, as a single-dose vial for intravenous infusion.

Can I order a single pack?
A.K. Pharma is a distributor and supplies bulk/wholesale quantities only, not one or two pieces.

How should Yervoy be stored?
As printed on the carton. The US label describes refrigeration at 2°C to 8°C in the original carton, protected from light, not frozen or shaken.

Does A.K. Pharma advise on dosing or suitability?
No. Treatment decisions, including dosing, rest solely with the treating physician and the approved prescribing information.

How do I request a quote?
Call or WhatsApp us, or use the contact details below.


Why Order from A.K. Pharma

  • Licensed pharmaceutical distributor in Delhi with 25+ years in specialty medicines
  • Genuine, original-pack stock
  • Bulk/wholesale supply to hospitals, oncology centres and pharmacies
  • Batch and expiry details on request
  • Dedicated team for hospital procurement queries

Sources and Further Reading


Contact A.K. Pharma for Yervoy Supply

📍 E-2/257A, 2nd Floor, Shastri Nagar, New Delhi 110052
📞 011 4172 6999
📱 WhatsApp: +91 9810034827
🌐 akpharma.in


Disclaimer: This page is intended for informational and sourcing/procurement purposes only and does not constitute medical or clinical advice. A.K. Pharma is a licensed medicine distributor, not a healthcare provider, and does not provide clinical guidance. All treatment decisions, including drug selection and dosing, rest solely with the treating physician and should follow the approved prescribing information.

Hi! 👋 Looking for a medicine? I can help you find it.

Quote Request Form


Quote Request Form